Genetic Diseases: Clinical Trials

1 trial for Genetic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Genetic Diseases: new trials by email Literature Review of Genetic Diseases trials Research Report on Genetic Diseases

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
AOC 1044, Placebo - Muscular Dystrophies, Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)
Phase 3RecruitingAvidity Biosciences, Inc.702026-09-012026-11-10

Narrower conditions

Genetic Diseases, Inborn (1)  ·  Infant, Newborn, Diseases (1)  ·  Muscular Diseases (1)  ·  Muscular Disorders, Atrophic (1)  ·  Muscular Dystrophies (1)  ·  Muscular Dystrophy, Duchenne (1)  ·  Musculoskeletal Diseases (1)  ·  Myotonic Dystrophy (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, X-Linked (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Myotonic Disorders (1)  ·  Neurodegenerative Diseases (1)

Sponsors

Avidity Biosciences, Inc. (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)